financetom
Business
financetom
/
Business
/
3M's PFAS Uncertainty, Free Cash Flow Constraints Temper Optimism Amid Positive Sentiment, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
3M's PFAS Uncertainty, Free Cash Flow Constraints Temper Optimism Amid Positive Sentiment, UBS Says
Jun 24, 2024 1:04 PM

03:44 PM EDT, 06/24/2024 (MT Newswires) -- 3M ( MMM ) has been riding on a wave of positive investor sentiment spurred by several factors including the recent appointment of a new chief executive, but caution is necessary, UBS said in a note Monday.

The appointment of Bill Brown as CEO, progress on per- and polyfluoroalkyl substances, or PFAS, cleanup and margin execution are positives for the company's stock but UBS analysts' optimism is dampened by continued weakness in revenue, uncertainty around remaining PFAS liabilities and limited free cash flow, according to the note.

The chemical manufacturer has agreed to contribute up to $10.3 billion over 13 years to public water systems that have found PFAS in drinking water.

"Such settlement would remove uncertainty, but with limited ability to assess the risk and related hit to free cash flow, valuation upside is limited in our view," UBS said.

And while the new CEO "could be a positive catalyst for the business over time," the firm said it is modeling flat organic sales for full-year 2024, which compares with consensus estimate of a 1% increase and is at the low end of flat to 2% growth guidance, UBS said.

UBS kept its neutral rating and $100 price target on 3M ( MMM ).

Price: 102.87, Change: +0.48, Percent Change: +0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hughes Expands Aviation, Space and Defense Expertise with Strategic Acquisition of Anderson Connectivity
Hughes Expands Aviation, Space and Defense Expertise with Strategic Acquisition of Anderson Connectivity
Oct 22, 2025
GERMANTOWN, Md., Oct. 22, 2025 /PRNewswire/ -- Hughes Network Systems, LLC (HUGHES), an EchoStar company , today announced it has acquired Anderson Connectivity, a leading aerospace innovator in design, engineering, and manufacturing services based in Melbourne, Florida. This acquisition significantly expands Hughes capabilities, adding key technology & engineering talent and product solutions while positioning the company for accelerated growth in the...
Reckoner Capital launches CLO ETF for BBB rated credits
Reckoner Capital launches CLO ETF for BBB rated credits
Oct 22, 2025
Oct 22 (Reuters) - Reckoner Capital will launch a new exchange-traded fund on Wednesday holding lower credit tiers within the collateralized corporate loan market, in the midst of growing questions about credit quality in the lending market. The new Reckoner BBB-B CLO ETF will make its debut as some of the largest ETFs in the collateralized loan obligation universe witness...
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million
Oct 22, 2025
Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The agreement includes 1) an upfront payment of $3.5 million, 2) potential future regulatory milestones, commercial milestones, and contingent value rights of up to $105 million. Biossil assumes all further obligations to Blackstone Life Sciences under...
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI
Shuttle Pharma Positions to Become the First Self-Learning Biotech After Definitive LOI to Acquire Molecule.AI
Oct 22, 2025
ROCKVILLE, MD / ACCESS Newswire ( ACCS ) / October 22, 2025 / Artificial intelligence has reshaped nearly every industry, but drug discovery has always been its toughest proving ground. Molecules don't follow patterns; they twist, bind, and defy prediction, humbling even the smartest algorithms. That's why Shuttle Pharmaceuticals Holdings ( SHPH ) just made one of the boldest moves...
Copyright 2023-2026 - www.financetom.com All Rights Reserved